Virtually all cellular processes are carried out by dynamic molecular assemblies or multiprotein complexes, the compositions of which are largely undefined. They cannot be predicted solely from bioinformatics analyses nor are there well defined techniques currently available to unequivocally identify protein complexes (PCs). To address this issue, we attempted to directly determine the identity of PCs from native microbial biomass using Pyrococcus furiosus, a hyperthermophilic archaeon that grows optimally at 100°C, as the model organism. Novel PCs were identified by large scale fractionation of the native proteome using non-denaturing, sequential column chromatography under anaerobic, reducing conditions. A total of 967 distinct P. furiosus proteins were identified by mass spectrometry (nano LC-ESI-MS/MS), representing ϳ80% of the cytoplasmic proteins. Based on the co-fractionation of proteins that are encoded by adjacent genes on the chromosome, 106 potential heteromeric PCs containing 243 proteins were identified, only 20 of which were known or expected. In addition to those of unknown function, novel and uncharacterized PCs were identified that are proposed to be involved in the metabolism of amino acids (10), carbohydrates (four), lipids (two), vitamins and metals (three), and DNA and RNA (nine). A further 30 potential PCs were classified as tentative, and the remaining potential PCs (13) were classified as weakly interacting. Some major advantages of native biomass fractionation for PC identification are that it provides a road map for the (partial) purification of native forms of novel and uncharacterized PCs, and the results can be utilized for the recombinant production of low abundance PCs to provide enough material for detailed structural and biochemical analyses. 
The repository of sequenced genomes is now above 850 (Genomes Online Database). Consequently there is a tremendous need to determine the function of gene products and identify groups of proteins that work together as complexes in distinct cellular processes. Genome-wide functional analyses suggest that there are 200 -300 core biological functions that are essential to life (1) . More often than not the functional units are assemblies composed of multiple proteins (2) . Many biological processes involve multiprotein complexes that function as large and efficient machines, such as ribosomes (3, 4) , flagella (5) , and cellulosomes (6) . In addition, the supramolecular organization of enzymes of partial or entire metabolic pathways as "metabolons" appears to provide certain advantages, such as substrate channeling (7) (8) (9) . The identification of protein-protein interactions and functional, stable associations is extremely important in understanding the biology of a cell. However, predicting the nature of such complexes within a single genome, let alone for hundreds of genomes, remains a major challenge.
Although there are currently several methods available to study protein-protein interactions on a genome-wide scale (10 -12) , each has severe limitations. The in vivo two-hybrid system (13) (14) (15) requires tagged proteins, is limited to binary interactions, and is thought to generate a large percentage of false positives (16) . The epitope tag affinity purification and tandem affinity purification methods have also been used extensively (17) (18) (19) (20) (21) , but the tags can disrupt native proteinprotein interactions, and the methods tend to be biased toward proteins that interact with high affinity and/or proteins of high abundance (10) . The major limitation with all of these approaches is that they require genetic manipulation of the target organism, an ability limited to only a few well studied systems. Non-genetic techniques to identify protein-protein interactions include co-immunoaffinity precipitation to capture endogenous protein complexes, but this is not a genomewide approach as it requires highly specific antibodies made against purified proteins (22) . Two-dimensional blue native/ SDS-PAGE and clear native-PAGE are also two widely used techniques that do not require genetic manipulation and allow for the analysis of protein complexes on a proteome-wide scale in a single experiment (23) (24) (25) (26) . However, they are limited in their dynamic range and typically identify only high abundance proteins (27) .
The goal of this research is to develop a global method to identify novel protein complexes (PCs) 1 independent of a genetic system and applicable to any organism with available native biomass. The approach involves multistep, non-denaturing column chromatography where the co-fractionation of proteins is used to identify potential complexes. As a model system we use the hyperthermophilic archaeon Pyrococcus furiosus, an anaerobe that grows optimally at 100°C (28) . Its genome sequence (29, 30) contains 2125 ORFs. A universal feature of prokaryotic genomes is the organization of genes into operons, which form basic transcriptional units (31) and are important in functional genomics. Using a neural network, we predicted that 1460 ORFs in the P. furiosus genome are contained within 470 operons (32) , 349 of which were validated using DNA microarray data (33, 34) . Operons typically encode functionally related proteins, which can include enzymes of the same pathway as well as heteromeric PCs. Herein heteromeric PCs encoded by two or more adjacent genes are referred to as Type 1 PCs, whereas heteromeric PCs encoded by two or more unlinked genes are referred to as Type 2 PCs. This pilot study focused on identifying stable, Type 1 heteromeric PCs in P. furiosus based on the cofractionation of proteins during sequential column chromatography steps. In addition, a high throughput (HT) system was devised to allow protein identification by nano-LC-ESI-MS/ MS. Our long term objective is to develop HT protocols for novel PC identification on a genome-wide basis using limited amounts of biomass.
EXPERIMENTAL PROCEDURES

Preparation of Anaerobic Cell-free Extract
P. furiosus (DSM 3638) was grown under anaerobic, reducing conditions at 90°C in a 600-liter fermenter on maltose and peptides and harvested in the late log phase (35) . The procedures for preparing anaerobic cell-free extract and for running the first chromatography step have been described previously (35) . Briefly 300 g of frozen cells were gently lysed by osmotic shock anaerobically under a continuous flow of argon in 900 ml of 50 mM Tris-HCl (pH 8.0) containing 2 mM sodium dithionite as a reductant (Buffer A) and 0.5 g/ml DNase I to reduce viscosity. The cell lysate was centrifuged at 100,000 ϫ g for 2 h at 18°C, and the clear supernatant, representing the cytoplasmic fraction, was immediately loaded onto the first column. This and all subsequent columns were run under anaerobic, reducing conditions where all buffers were degassed and maintained under a positive pressure of argon, and all liquid transfers were made using needles and syringes.
Large Scale Anaerobic Fractionation of Cytoplasmic Proteins
First Column (c1) Fractionation-A column tree representing the complete fractionation procedure is shown in Fig. 1 . All columns were run using an Ä KTA TM basic automated LC system (GE Healthcare). The P. furiosus cytoplasmic fraction was diluted 4-fold in Buffer A to reduce the ionic strength and was loaded onto a 10 ϫ 20-cm (1.5-liter) column of DEAE-Sepharose Fast Flow (GE Healthcare) that had been equilibrated previously with the same buffer until the effluent was anaerobic and reducing. Unbound protein was washed off the column with Buffer A. Bound proteins were eluted using a linear gradient (15 liters) of 0 -500 mM NaCl in Buffer A, and 125-ml anaerobic fractions were collected (120 fractions). Any remaining tightly bound proteins were eluted from the column using 1-liter step gradients of 1, 1.5, and 2 M NaCl, respectively, in Buffer A (high salt washes).
Second (c2) Level Column Fractionations-A subset of 37 gradient fractions from the first column separation were selected using a combination of protein profiles and enzyme activities to create six fraction pools, c1-1 through c1-6. The control proteins and enzyme FIG. 1. Column tree showing the four levels (c1-c4) of chromatography steps used to fractionate P. furiosus cytoplasmic proteins. The cytoplasmic proteins were fractionated using DEAE Fast Flow anion exchange chromatography as the first step (c1). Fractions from the first column were selected and combined to generate 15 pools that were fractionated through subsequent second (c2) and, for some control proteins, third (c3) and fourth (c4) level columns. The chromatography steps included hydroxyapatite (HAP), phenyl-Sepharose (PS), Superdex 200 (SX200), and blue Sepharose (BS), and these are indicated.
activities were as follows: c1-1, ferredoxin-NADPH oxidoreductase (FNOR) (36) and rubrerythrin (37); c1-2, 2-ketoisovalerate ferredoxin oxidoreductase (VOR) and pyruvate ferredoxin oxidoreductase (POR) (38) ; c1-3, aldehyde:ferredoxin oxidoreductase (39) and NADPHrubredoxin oxidoreductase (40); c1-4, soluble hydrogenase 1 (SH1) (41); c1-5, rubredoxin (42) ; and c1-6, ferredoxin (Fd) (43) . These pools, c1-1 through c1-6, were fractionated through six subsequent c2 columns. The remaining 83 gradient fractions were combined to generate nine additional pools, in this case based solely on SDS-PAGE and protein profiles. These pools, c1-7 through c1-15, were fractionated through nine subsequent c2 columns to give a total of 15 columns at the c2 level (Fig. 1) . SDS-PAGE and native PAGE were carried out using precast 4 -20% gradient gels (Criterion gel system, Bio-Rad). Protein concentrations were estimated by the method of Bradford (44) using bovine serum albumin as the standard.
Third (c3) and Fourth (c4) Level Column Fractionations-Six c3 and four c4 level columns were run using fraction pools that were created for the further purification of the control proteins by the published procedures (Fig. 1) . Detailed information about the individual c2, c3, and c4 column chromatography steps is summarized in supplemental Table 1 .
Protein Identification Using Mass Spectrometry
Protein Digestion-The steps for denaturation, reduction, alkylation, and digestion were automated for most samples using 96-well plates and a MassPrep robotic liquid handler (Waters, Milford, MA). To each well containing 50 l of a fraction sample was added 50 l of pure trifluoroethanol. The plate was heated to 60°C for 30 min to complete the denaturation process. Disulfide bonds were reduced by adding 10 l of dithiothreitol (200 mM in 50 mM ammonium bicarbonate) and alkylated by adding 14 l of iodoacetamide (200 mM). After incubation for 30 min in the dark at 25°C, the protein was digested for 18 h at 40°C using 1.5 g of trypsin (Trypsin Gold mass spectrometry, Promega, Madison, WI). Digestion was halted by lowering the pH to 4 by the addition of 5% formic acid.
Separation of Peptides and Mass Spectrometry-Two methods were used for separation. A longer gradient was used for more complex samples, whereas a shorter gradient was used in a rapid HT LC-MS/MS analysis of less complex samples. A 96-well plate-based HT method was devised to rapidly separate peptides by reverse phase LC or MS/MS analysis using a two-pump setup. Using an Agilent 1100 microwell autosampler, 8 l of the digested sample was injected and transported at 50 l/min (using a quaternary pump) through the dead volume of a microwell autosampler to a C 18 trap cartridge on a six-port switching valve. After 3 min, the flow was switched to the nanocapillary pump at a flow rate of 500 nl/min. An analytical column/nanoelectrospray tip (75-m inner diameter, 6 cm in length) fabricated with a P-2000 (Sutter Instruments) laser puller and packed with C 18 resin (5 m; Agilent Zorbax SB) under high pressure was used to separate the peptides prior to their analysis with an LTQ mass spectrometer in data-dependent MS/MS mode. The reverse phase gradient separation was performed using water and acetonitrile (0.1% formic acid) as the mobile phases. For the HT LC-MS analysis, the gradient consisted of 20 -35% acetonitrile over 20 min to 90% over 8 min prior to equilibration in 5% acetonitrile (0.1% formic acid) for 15 min before reinjection. For more complex c1 protein samples, a longer, conventional (CV) gradient elution was used consisting of 5-8% acetonitrile over 5 min to 35% over 113 min, to 55% over 12 min, and then to 98% maintained for 15 min (wash) before re-equilibration at 5% for 15 min.
MS/MS analysis was performed on the LTQ linear ion trap mass spectrometer (Thermo Fisher Scientific Inc.) using 2 kV at the tip. One MS spectrum was followed by four MS/MS scans on the most abundant ions after the application of the dynamic exclusion list. The LTQ software utility extractmsn.exe (Thermo Fisher Scientific Inc., version 3, September 27, 1997-2007) was used to peak pick and extract peak lists from the tandem mass spectra into peak list (.dta) files. Mascot Daemon was used to run this program externally and to submit the searches to Mascot (Matrix Science Ltd.) for protein identification. The Mascot searches were conducted at a 95% confidence level using tryptic peptides derived from the public National Center for Biotechnology Information (NCBI) annotation of the P. furiosus genome (NC_003413, December 2, 2007) (29, 30) containing a total of 2125 protein sequences. The false positive rate was estimated by searching 20 data sets of P. furiosus LC-MS/MS data against a decoy database containing reverse sequences from the P. furiosus genome. A Mascot ion score threshold of 35 for the 20 searches yielded an acceptable and low false positive rate of 0.398 Ϯ 0.57%. Thus, the Mascot ion score threshold was set to 35 for all searches, including single peptide assignments, so that the false positive rate was consistently less than 1%. Furthermore there was little issue with the peptides matching multiple members of a protein family because of the use of a single small proteome. Mascot was searched with a fragment ion mass tolerance of 0.80 Da and a parent ion tolerance of 2.0 Da. Iodoacetamide derivative of cysteine and oxidation of methionine were specified as fixed and variable modifications, respectively. The enzyme was selected as trypsin with a maximum of one missed cleavage allowed for the search. The fragmentation pattern was optimized for the instrument used by selecting the Mascot search parameter as "ESI-trap." The MS/MS data for all unique peptides identified for each protein are presented in supplemental Table 2 .
Data Management
All MS/MS data were stored in a custom Structural Query Language (SQL) Server 2005 database that preserves the hierarchical (parent-child) nature of the multilevel fractionation process. All samples analyzed were assigned two-dimensional barcodes. A user interface developed in Microsoft Access 2003 shows the hierarchical fractionation steps and automatically generates a Microsoft Excel PivotTable for each column that displays the proteins identified by MS/MS along the rows, chromatography fractions along the columns, and the number of peptides detected where they intersect.
Protein Complex Identification
Identification of potential Type 1 PCs was accomplished by generating text-based PivotTables (described above) for each of the 26 column chromatography steps. The text files were processed by a custom script written in the R statistical language. For each column, this script created a number of tentative PCs consisting of proteins that (i) co-eluted in one or more column fractions and (ii) were encoded by adjacent genes on the same DNA strand (Type 1 PCs). These tentative PCs from each column that contained any proteins in common were merged to generate a final list of potential PCs and assigned unique PC identification numbers.
Protein Complex Evaluation
The quality of the predicted PCs (i.e. the association value) was evaluated using a custom algorithm applied to the column data contained in the PivotTable described above (restricted to the potential subunits identified in the prediction step). This algorithm may be used for evaluating both Type 1 and Type 2 PCs. For each predicted PC, the algorithm computes a per fraction subscore based on the proportion of potential subunits within the predicted PC that appear in that fraction and sums these subscores to produce an overall raw score. The assigned subscores range from Ϫ0.1 (when half of the potential subunits are observed in a fraction) to 1.0 (when all of the potential subunits are observed in a fraction) with a zero score assigned when none of the subunits are observed in a given fraction. Specifically the function used to assign the subscores is the piecewise linear function with one linear piece between the points (0, 0) and (0.5, Ϫ0.1) and another linear piece between (0.5, Ϫ0.1) and (1, 1). The points of the function were selected based on 14 known PCs by optimizing over piecewise linear functions (with points (0, 0), (0.5, y0), and (1, y1), Ϫ2 Յ y0 Յ 0 and 0 Յ y1 Յ 2) so that the sum of the positions of the known PCs within the resulting PC list, sorted by score (in descending order), was minimized. Raw scores for putative complexes (Ϫ13.6 to 43.1) were rescaled in a relative fashion to lie within the interval [0, 1].
Protein Annotations
The protein annotations are based on the public National Center for Biotechnology Information (NCBI) annotation of the genome (45) except where the protein or protein complex (a) is known and has been previously purified from P. furiosus (indicated by a reference), (b) shows sequence similarity to a known protein or protein complex purified from a closely related organism (also referenced), or (c) was listed as a hypothetical protein but has a known domain in the InterPro database (46) .
RESULTS
Fractionation of Cytoplasmic Proteins Using Column Chromatography
Fractionation was carried out under anaerobic and reducing conditions using sequential, non-denaturing, column chromatography to determine which proteins co-fractionated as potential multiprotein complexes. The cytoplasmic fraction was initially resolved by anion exchange chromatography (column level c1) into 126 fractions. The c1 fractions were analyzed by MS/MS, and the results are summarized in Fig. 2 along with the protein concentration profile. CV LC-ESI-MS/MS was used for c1 fractions containing the bulk of the protein as determined by protein concentrations and overall protein profile (fraction positions 31-75 of 126), whereas the new HT LC-ESI-MS/MS methodology, capable of handling 96-well format plates in a much shorter time and developed for this project, was used for the lower complexity fractions. Ten fractions were analyzed using both approaches to evaluate the efficacy of the HT method (Fig. 2) . A total of 403 proteins were identified in these fractions, 387 by CV MS/MS and 111 by HT MS/MS (with 95 proteins in common). For more complex fractions containing at least 60 proteins identified by CV MS, typically less than 25% were identified by HT MS, whereas for less complex fractions containing 20 or so proteins (by CV MS) the two methods identified a similar number of proteins. Only the HT approach was used to analyze all c2, c3, and c4 fractions. A total of 696 proteins were identified in the c1 fractions by the two approaches.
To gain insight into which potential PCs remain associated after additional separation procedures, the c1 fractions were combined into 15 pools (see Fig. 2 ), and each was subjected to a c2 chromatography step. Pooling was based on the location of abundant proteins within the fractions as determined by SDS-PAGE and specific enzyme assays, minimizing the division of major proteins into multiple c2 columns and providing known, stable heteromeric PCs that should co-elute through multiple separation steps and serve as positive controls for detection by HT MS/MS. Four assayable heteromeric PCs (abbreviated FNOR, POR, VOR, and SH1) were chosen for this purpose. In addition, five known homomeric PCs served as negative controls for the co-fractionation analysis. These included three oxidoreductases, aldehyde:ferredoxin oxidoreductase, rubrerythrin, and NADPH-rubredoxin oxidoreductase, and two small redox proteins (rubredoxin and Fd) that are electron carriers for numerous oxidoreductasetype enzymes. None of these five proteins are known to form heteromeric PCs that are stable through multiple separation steps.
As shown in Fig. 1 , the c1 fraction pools were fractionated through second level (c2) columns generating a total of 790 c2 fractions. To further purify the control proteins, six c2 fraction pools (ϳ5.3% of the total c2 fractions) were fractionated on c3 columns, and four c3 fraction pools (ϳ13% of the total c3 fractions) were fractionated on c4 columns. The c3 and c4 columns yielded 229 and 131 fractions, respectively. Overall the cytoplasmic extract was resolved into 1276 fractions, and an additional 280 proteins were identified in the c2-c4 fractions that were not found in the c1 fractions. The total number of proteins identified was 976, representing 46% of the predicted proteome (supplemental Tables 2-4). Given that the genome contains 2125 ORFs, 75% of which are expressed under a given growth condition (33) with ϳ25% of those being membrane-associated (47), the upper limit for the number of different cytoplasmic proteins is about 1200. Approximately 80% of these were identified, showing the validity of the HT MS approach for less complex fractions.
Identification and Distribution of Potential Type 1 Heteromeric Protein Complexes
Identification of potential heteromeric PCs was carried out computationally using the MS/MS data generated for each fraction. Proteins that co-fractionated and were encoded by adjacent genes made up 243 or 25% of the total number of proteins identified. These proteins are predicted to form 106 potential Type 1 PCs (labeled PC-1 to PC-106; supplemental Table 5 ). Components from 71 of these were identified in c1 fractions as well as in the downstream c2, c3, and/or c4 fractions, whereas the remaining 35 were detected in downstream fractions only, either in fractions from a single column (26 PCs) or in fractions from multiple columns (nine PCs). A total of 32 of the 71 were identified as PCs only in c1 fractions.
Known PCs (15)
A total of 61 of the 243 proteins that constitute the 106 potential PCs are classified as known because they have been purified previously from P. furiosus. Of these, 43 are components of 15 potential PCs identified in the unbiased assessment based on the fractionation procedure (Tables I  and II) and include the four PCs that were used as positive controls for the fractionation procedure (FNOR, POR, VOR, and SH1). One of these predicted complexes (PC-34; see Table I ) actually represents two of the positive control PCs (POR and VOR) that are encoded by adjacent genes (PF0965-PF0971), one of which (PF0971) encodes a common subunit (61) . Consequently the 43 proteins are actually components of 16 known PCs. The identification of these known PCs validates the criteria that were used to identify novel PCs.
Thirteen of the known PCs have been purified previously from P. furiosus biomass, whereas three (PC-5, PC-26, and PC-46) have been characterized using recombinant proteins. Two PCs represent soluble subcomplexes of known membrane-bound PCs, ATP synthase (A 1 subcomplex: PC-10 (52)) and the membrane-bound hydrogenase (MBH: PC-56; (57)). In one instance, only two component proteins of a known heterotetrameric PC, hydrogenase II (PC-50 (56)), were detected in any fraction at any level, whereas three PCs were each predicted to contain an additional subunit (PC-5: replication factor C complex (50), PC-2: DNA polymerase II (49), and PC-65: DNA topoisomerase (59)). The third component of one of them (PC-5) has also been purified (protein-disulfide oxidoreductase (51, 62) ). It is possible that all three potential PCs are functional complexes that dissociate upon purification. All the known PCs are predicted to be encoded by operons (32) with the exceptions of the third components in the trimeric PCs noted above (PC-2 and PC-5), supporting the notion that they are dimeric PCs (see Table I ). Association scores for all the known complexes were above 0.2 with the exception of PC-10, the subcomplex of the ATPase. Excluding one member of the complex (PF0181) results in a much higher score (0.48), suggesting that PF0181 is weakly associated.
Expected PCs (5)
Five potential Type 1 PCs containing 12 proteins were categorized as expected PCs because homologous complexes have been characterized from related organisms ( Table III and supplemental Table 5 ). These PCs are involved in protein biosynthesis (PC-37 (63) and PC-58 (64, 65) ), RNA processing (PC-63 (66)), central carbon metabolism (PC-74 (67)), and amino acid metabolism (PC-76 (68)). The expected PCs had association scores in the range of 0.2-0.3 and, with one exception (PC-58), are predicted to be encoded by operons.
Novel Potential PCs (86)
The remaining 86 potential Type 1 PCs have been categorized as novel PCs in that they were not anticipated and/or have not been characterized previously. Thirteen of them have orthologous interactions in the Escherichia coli and/or Saccharomyces cerevisiae (European Bioinformatics Institute Int-Act database (Refs. 69 and 70; see supplemental Table 6 ). These were analyzed using additional criteria that included homology, the extent of overlap between component proteins, abundance of protein partners (number of fractions in which they were identified), operon structure, and evidence for co-regulation from DNA microarray data. Based on this information, the novel potential PCs were categorized as strong (43 PCs), tentative (30 PCs), or weak (13 PCs) (Tables  IV, V , and VI, respectively). Some of the biological implications of the identified strong PCs are discussed below. Strong, Novel Potential PCs and Their Biological Implications-Properties of the 43 strong, novel potential PCs are summarized in Table IV . All have association scores of Ն0.2 and the majority (39 PCs) are predicted to be encoded by operons.
P. furiosus utilizes peptides as a carbon source (28) , and a pathway for amino acid catabolism has been proposed ( Fig.  3 ; Refs. 61, 87). The various 2-ketoacids produced from amino acids by aminotransferases are converted to the CoA derivative by four heteromeric Fd-linked 2-keto acid oxidoreductases (KORs) that were all identified in this study.
These are specific for pyruvate (POR: PC-34 (48)), aromatic (indolepyruvate ferredoxin oxidoreductase: PC-22 (53)), branched chain 2-keto acids (VOR (␣␤␥␦): PC-34 (88)), and 2-ketoglutarate:ferredoxin oxidoreductase (␣␤␥␦: PC-74 (expected) (67)). The acyl-CoA derivatives generated are used for ATP synthesis by two heteromeric (␣ 2 ␤ 2 ) ADP-dependent acyl-CoA synthetases (ACSs), ACS I (PF1540/PF1787) and ACS II (PF0532/PF1837) (73); however, these are Type 2 PCs (encoded by unlinked genes) and would not be identified as complexes by the present methodology.
The P. furiosus genome contains genes that encode two additional KOR paralogs (38) and three paralogs of the ACS ␣ subunits, all of unknown function. We have now identified PCs corresponding to the two unknown KOR paralogs (Fig. 3 , PC-30 and PC-75), which presumably extend the repertoire of amino acid derivatives that are utilized by the KORs. We also identified an additional ACS complex (PC-81; PF1837/ PF1838) that shares a subunit (PF1837) with ACS II. Both ACS ␤ subunits and all five ACS ␣ subunits were identified in the fractionation procedure (supplemental Table 3 ). The fact that at least one ␤ subunit (PF1837) can form two distinct PCs with two ␣ subunits (PF0532 and PF1838) indicates that the two ␤ subunit paralogs may assemble with two or more ␣ subunits to give a variety of Type 1 and Type 2 PCs. An additional PC (PC-35), composed of two proteins that are annotated as an acyl carrier protein and acetyl-CoA synthase, has been identified that may convert the acyl-CoAs generated by amino acid oxidation to as yet unknown products (see Fig. 3 ). In support of this, the expression of the genes encoding both components of PC-35 (PF0972/PF0973) are up-regulated when P. furiosus is grown on peptides (33, 38, 89) . Another potential PC (PC-7) contains a component that is a paralog of the KOR ␥-subunit, although its function is unknown.
As shown in Fig. 3 , the reductant generated from amino acid oxidation reduces the redox protein Fd, which is subsequently used to reduce NAD(P) by the known PC, FNOR I (PC-49 (36)). We have now identified a paralog of FNOR I, PC-85, that is termed FNOR II. DNA microarray studies have shown that the expression of FNOR I and FNOR II is reciprocally regulated when P. furiosus is grown on peptides and carbohydrates (33) , indicating that they catalyze the same reaction but have different physiological roles. PC-85 includes the known electron carrier protein Fd (43) . Although Fd is not predicted to be part of the FNOR II operon, it does take part in the FNOR I reaction and would be predicted to interact with FNOR II. The association score for PC-85 was found to increase from 0.1 to 0.22 on removing Fd from the complex, indicating that it may be a weakly interacting component.
Based on their annotations, four PCs appear to be directly involved in the metabolism of amino acids: PC-47 (methionine), PC-91 (glycine), PC-69 (arginine), and PC-103 (leucine) ( Table IV) . The components of PC-103 (PF1679/PF1680) are annotated as subunits of a putative 3-isopropylmalate dehydratase and have paralogs (PF0938/PF0939) within the
TABLE II Fractionation grid for control and known PCs
This table shows the proteins (indicated by their PF number) identified by LC-MS/MS along rows and the chromatography step along the columns. The squares generated where they intersect are colorcoded dark gray if the identified PC components co-eluted in the same fractions from a particular column and light gray if a PC component eluted separately in the fractions of a particular column. Blank squares denote that the protein was not identified in any fractions of that column. leucine biosynthesis operon that are more likely to encode the true 3-isopropylmalate dehydratase. Based on a study with the closely related species Pyrococcus horikoshii (90), PC-103 is more likely to be involved in lysine biosynthesis. PC-69 is annotated as carbamoyl-phosphate synthetase, and we have previously presented evidence indicating that it is involved in arginine biosynthesis (33) . This heterodimeric carbamoyl-phosphate synthetase is distinct from the (monomeric) carbamate kinase-like enzyme (PF0676) previously purified from P. furiosus that was incorrectly termed a carbamoyl-phosphate synthetase (91) .
Four PCs appear to be involved in various aspects of carbohydrate metabolism, one in the tricarboxylic acid cycle (PC-12) and three concerned with monosaccharide phosphate derivatives (PC-52, PC-72, and PC-101). All of these PCs are predicted to be encoded by operons with the exception of PC-101, which is proposed to encode a carbohydrate kinase and a NUDIX protein. The latter is a type of NDP hydrolase, and the crystal structure of a recombinantly produced ortholog (expressed using a single gene) from a hyperthermophilic archaeon is known (92) . Given the unknown function of these proteins in hyperthermophiles such as P. furiosus, a physiological heteromeric complex is a possibility.
PC-92 is a heterotrimeric complex with two components that indicate an involvement in the oxidation of glycerol phosphate. The third component (PF2007) is a basic hypothetical protein, but it appears to be a real component as the three proteins co-purify to the c3 level and are encoded by an operon. PC-6 appears to be a redox-active complex involved in isoprenoid biosynthesis based on the annotations of its two components.
PC-60 appears to be involved in the biosynthesis of the B-type vitamins pyridoxal and thiamine, whereas two potential PCs (PC-48 and PC-24) are proposed to be involved in the metabolism of iron and nickel (Table IV) . PC-48, a five-component complex, contains three proteins homologous to those involved in iron-sulfur cluster biosynthesis that have been previously characterized individually from bacteria (Suf-CBD (93)). The other two components of PC-48, a histone-like protein (PF1284) and ruberythyrin (PF1283), an enzyme previously purified from P. furiosus as a homomeric protein (37) , are unlikely to be true components because they only cofractionate with the SufCBD complex at the c1 level and are not part of the predicted SufCBD operon (Table IV) . Indeed the association score for PC-48 increases from 0.16 to 0.35 when PF1283 and PF1284 are excluded.
PC-24 is proposed to be involved in nickel metabolism. P. furiosus evolves hydrogen gas and contains three distinct hydrogenases, all of which contain a nickel-iron ([NiFe]) catalytic site (94) . The genome encodes homologs for proteins that are known to be required for the biosynthesis of the [NiFe] site, and two of them, HypC and HypD, are components of PC-24 (Table IV) . These two proteins appear to form a weak/ transient complex in bacteria (Refs. 95 and 96; supplemental Table 6 ) but in P. furiosus remain together after four levels of chromatography, indicating that PC-24 forms a strong complex. PC-24 is found in c4 fractions containing PC-33, the cytoplasmic hydrogenase I (SH1), suggesting that it may form a stable complex with this enzyme (supplemental Table 5 ). This aspect is currently under further study.
Several potential PCs are involved in various aspects of nucleotide and polynucleotide metabolism. PC-11, a heterodimeric complex, is involved in purine biosynthesis, whereas two PCs are paralogous complexes (PC-9 and PC-64) that appear to be involved in modulating the activity of DNA gyrase. In P. furiosus, this is presumably the unusual DNA topoisomerase or reverse gyrase that is unique to hyperthermophilic organisms (97) . Coincidentally another potential PC that may be involved in DNA binding (PC-82) is annotated as a chromosome segregation protein (98) . It appears to be a low abundance PC because the component proteins were only found in a total of four fractions (Table  IV) . PC-95 might bind RNA and also contains a chaperonetype protein. Another group of potential PC components are homologs of the clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated (cas) system. CRISPRs are a distinctive feature of the genomes of most prokaryotes and, along with cas genes, are thought to be involved in resistance to bacteriophages and constitute a bacterial immune system similar to that of RNA interference in higher organisms (99 -101) . P. furiosus has two identified CRISPR/cas regions containing 23 potential cas genes in the genome (99) . Seventeen putative Cas proteins were identified in this fractionation, providing the first evidence for the presence of Cas proteins in the native proteome (supplemental Table 3 ). Twelve were found in four Type 1 PCs (Table IV) . The genes for two of these (sub)complexes (PC-28 and PC-29) are predicted to form a single operon (32) , and transcriptional analysis indicates that the genes are down-regulated in cold-adapted cells (34) . Also down-regulated are two more genes within this operon whose products form PC-27, which is in the tentative PC category (discussed below; see Table V ). The genes for the remaining two (sub)complexes, PC-40 and PC-41, are in three contiguous operons and appear to be up-regulated in cells grown on carbohydrates relative to peptides (33) . Whether these proteins play a role as an archaeal immune system remains to be seen. A total of 44 ribosomal proteins were identified in the native fractionation (supplemental Table 3 ). Twenty-two of these formed five strong, four tentative, and three weak potential PCs (Tables IV, V , and VI, respectively). The multiple (sub)complexes are likely a consequence of not detecting many ribosomal proteins by the HT MS/MS technique. For example, as shown in supplemental Table 5 , PC-77, PC-79, and PC-104 were identified in c2 fractions, but all seven component proteins are predicted to be part of the same operon.
For many of the strong PCs, there is no indication of their true function as their components are classified as "hypothetical" and/or are poorly annotated. For example, PC-17 is composed of two very abundant (found in at least 47 fractions) hypothetical proteins encoded by a predicted operon (with an association score of 1.0) that are highly likely to be a stable complex. In some cases, the general function of one subunit is known, e.g. PC-42 where one component is a flavoprotein and the other is a hypothetical protein. Some PC components are annotated as homologs of proteins in higher eukaryotes, such as PC-51 (a von Willebrand factor homolog), whereas in others annotations are hard to rationalize. For example, PC-98 contains an acidic pilin-related protein and a very basic conserved hypothetical protein.
Tentative Novel PCs (30)-Thirty potential PCs containing 61 proteins were identified that are defined as tentative because they were detected as complexes only in c1 fractions (Table V and supplemental Table 5 ). Some are likely to be true PCs whose partners were simply not identified by HT MS/MS in the c2-c4 fractions. These include 11 PCs that are predicted to be encoded by operons and have association scores of Ն0.2. Many are also likely to be in low abundance PCs; in fact, six complexes were found only in c1 fractions that were analyzed by CV MS/MS (PC-18, -27, -55, -73, -78, and -93) and were not detected by HT MS/MS. Several PCs have protein components with predicted basic pI values (Ͼ8.0) suggesting that they would not bind to an anion exchange column (c1) unless they were part of a true (acidic) multiprotein complex Weak or Unlikely Novel PCs (13)-Thirteen PCs containing 27 proteins fall into this category where one or both of their components are abundant proteins found in many fractions but typically not in the same one(s), i.e. they appear to fortuitously co-elute with their proposed partner in a few fractions (Table VI) . This is reflected in their association scores (Ͻ0.2) and includes five proteins that have been previously characterized from P. furiosus as homomeric proteins. For example, phosphoenolpyruvate synthase (82) was found in over 150 fractions, whereas its proposed partner in PC-4, a seemingly unrelated metallohydrolase, was found in only six fractions. Moreover the genes encoding the two proteins are not predicted to be in an operon, and the association score is 0. Conversely argininosuccinate synthase and argininosuccinate lyase (PC-13) are enzymes of the same pathway and potentially could form a weakly interacting complex. Additional experimentation will be necessary to test the validity and/or strength of this and other PCs listed in Table VI .
DISCUSSION
Experimental Approach for Identification of PCs-In this pilot study, the cytoplasmic extract of native biomass, which contains soluble PCs not removed (sedimented) by ultracentrifugation, was fractionated using sequential, non-denaturing chromatography steps. These included anion exchange, hy- droxyapatite, hydrophobic interaction, affinity, and size exclusion. The fractionation was carried out using anaerobic conditions to maintain the integrity of any oxygen-sensitive PCs, e.g. those containing redox-sensitive metal cofactors, that might dissociate if cofactors are lost (35) . Use of the native proteome also eliminated the problems associated with tagged and two-hybrid approaches for PC identification. Proteins were identified using a combination of CV and HT MS/MS on individual fractions generated at each chromatography level, whereas the identification of potential PCs utilized the MS/MS data in combination with co-fractionation data and bioinformatics analysis. This took advantage of the idea that gene clustering in prokaryotes can imply functional coupling (102, 103) . Approximately 60% of the P. furiosus genes are predicted to be in operons (32) ; however, which of these encode stable protein complexes is not known. Our approach led to the initial identification of 106 potential Type 1 PCs. While this work was in progress, a similar method was re- ported in which aerobic purification of E. coli proteins was coupled to a sophisticated, quantitative MS-based analysis. However, in that study, only three previously known and very abundant protein complexes were identified (104) . Similarly quantitative MS-based proteomics have also been applied to high molecular weight complexes in organelles separated by gradient centrifugation (105) .
Analysis of Potential PCs
Identified-Analysis of all the fractions at each level of column chromatography using MS/MS allowed us to follow individual proteins through each fractionation level. As a result, 30 potential PCs identified at the c1 level were categorized as "tentative" based on the fact that the component proteins were not identified in the same fraction in any of the downstream columns (Table V and supplemental Table 5 ). Although some of these c1 complexes probably represent weak or false PCs, it is also possible that a number of them are true complexes that were not identified in c2-c4 fractions by MS/MS. This is supported by the fact that 35 of the 106 complexes found in downstream columns were not identified as PCs in the c1 column. Thus, although these proteins were clearly present in the fractionation, they were not detected in the MS/MS analysis of the more complex c1 fractions. The HT MS approach makes the procedure much more high throughput, but it is not as sensitive as the CV method.
The effectiveness of the MS/MS approaches used in the identification of proteins is understandably affected by the complexity of the protein mixture and the presence of abundant proteins. This is evident at the column level where new proteins were detected as the complexity decreased (supplemental Table 4 ) and also at the fraction level where, even for known PCs, all of the component proteins were either not identified or were not identified together at every column level (see Table II and supplemental Table 5 ). In addition, one known complex (PC-106) and several expected complexes were identified as PCs only in post-c1 columns (supplemental Table 5 ). Clearly MS/MS does not identify all of the component proteins in PCs even when they are present. This can be extrapolated to the unknown PCs that have been identified in this study. Multilevel MS/MS also enabled us to look at the extent of overlap between potential components of PCs within the individual fractions of each column at each level. Thus, potential PCs with partners that overlapped minimally (were present in one or two fractions but separate in additional fractions) were categorized as "unlikely" or "weak." This method also allowed the identification of "abundant" proteins that are present at relatively high intracellular concentrations and often form part of the "core" proteome or are involved in central metabolism for a specific growth condition, such as ribosomes, chaperones, and major metabolic enzymes. Identification of "high abundance" partners in PCs that could arise as a result of nonspecific co-occurrence was based on the number of fractions in which they were identified.
Based on this pilot fractionation, we are currently developing HT analytical scale HPLC-based methods to reduce the amount of native biomass required and thus widen the applicability of the approach. Moreover this approach would also enable a more complete analysis of P. furiosus PCs because only 5% of the c2 fractions were fractionated onto c3 columns, and only 12% of those fractions were analyzed on c4 columns. A more comprehensive HT fractionation would include c3 columns that represent all c2 fractions, and all c3 fractions could be analyzed by c4 columns. This would maximize the number of proteins identified as the c4 fractions would be of low complexity, making it possible to identify Type 2 complexes as well as additional low abundance complexes. The use of the calculated association values appears to be an excellent criterion for assessing the validity of the potential PCs (supplemental Table 5 ). In addition, a major advantage of native biomass fractionation is that it provides a road map for the (partial) purification of all identified proteins, not only potential PCs, whereas low abundance PCs can be targeted for recombinant protein production by co-expression of the relevant genes.
